- Home
- INBX vs OXSQ Comparison
INBX vs OXSQ Comparison
Compare INBX & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- OXSQ
- Stock Information
- Founded
- INBX 2010
- OXSQ 2003
- Country
- INBX United States
- OXSQ United States
- Employees
- INBX N/A
- OXSQ N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- OXSQ Blank Checks
- Sector
- INBX Health Care
- OXSQ Finance
- Exchange
- INBX Nasdaq
- OXSQ Nasdaq
- Market Cap
- INBX 198.2M
- OXSQ 190.1M
- IPO Year
- INBX 2020
- OXSQ N/A
- Fundamental
- Price
- INBX $14.05
- OXSQ $2.59
- Analyst Decision
- INBX Hold
- OXSQ
- Analyst Count
- INBX 1
- OXSQ 0
- Target Price
- INBX N/A
- OXSQ N/A
- AVG Volume (30 Days)
- INBX 100.7K
- OXSQ 447.9K
- Earning Date
- INBX 05-08-2025
- OXSQ 05-01-2025
- Dividend Yield
- INBX 6.06%
- OXSQ 16.22%
- EPS Growth
- INBX N/A
- OXSQ N/A
- EPS
- INBX 112.62
- OXSQ 0.09
- Revenue
- INBX $200,000.00
- OXSQ $42,683,205.00
- Revenue This Year
- INBX N/A
- OXSQ $8.73
- Revenue Next Year
- INBX N/A
- OXSQ N/A
- P/E Ratio
- INBX $0.12
- OXSQ $28.17
- Revenue Growth
- INBX N/A
- OXSQ N/A
- 52 Week Low
- INBX $10.80
- OXSQ $2.40
- 52 Week High
- INBX $18.95
- OXSQ $3.29
- Technical
- Relative Strength Index (RSI)
- INBX 52.88
- OXSQ 38.55
- Support Level
- INBX $13.51
- OXSQ $2.51
- Resistance Level
- INBX $14.64
- OXSQ $2.61
- Average True Range (ATR)
- INBX 0.74
- OXSQ 0.05
- MACD
- INBX -0.03
- OXSQ -0.00
- Stochastic Oscillator
- INBX 45.85
- OXSQ 36.36
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing, and Diversified Insurance.